Introduction
Differences in the pharmacological properties of the various 3-blocking agents affect both their therapeutic action and their adverse effects (Petrie et al., 1976) . Manifestations of an overdose of Pblocking drugs include bradycardia, hypotension, low cardiac output failure and cardiogenic shock (Khan and Muscat-Baron, 1977) . Most P-blockers are classified as class I and II according to their antiarrhythmic properties. Contrary to other P-blocking drugs, sotalol has been found, experimentally, to possess class III antiarrhythmic action (Singh and Vaughan Williams, 1970) .
A case is reported of sotalol-induced recurrent atypical ventricular tachycardia, 'torsade de pointes' (Krikler and Curry, 1976 (Coltart, Gibson and Shand, 1971) . Sotalol hydrochloride, a nonselective P-blocking drug without intrinsic sympathomimetic and membrane stabilizing activity has been found experimentally to prolong the duration of the action potential and the QT interval (Singh and Vaughan Williams, 1970 
